KIRLOSIND NSE filing

Kirloskar Industries Reports Strong Q2 FY26 Results; Announces Key Board and KMP Appointments

The RealCase readHigh impact Positive

Kirloskar Industries reported strong Q2 FY26 standalone and consolidated results with increased revenue and profit. The company also announced several key board and KMP appointments, including new independent directors and a CFO.

Why it matters

The announcement includes the company's latest quarterly financial performance, which is a primary indicator of its health and future prospects. Additionally, multiple significant board and KMP appointments, along with a postal ballot for director approvals, indicate material changes in leadership and governance structure, warranting a high impact.

The market read

The company reported significant increases in both standalone and consolidated revenue and profit after tax for the quarter ended 30 September 2025. The appointment of new directors and a CFO also suggests strengthening of governance and management, contributing to a positive outlook.

* Kirloskar Industries Limited announced its standalone and consolidated unaudited financial results for the quarter and six months ended 30 September 2025, approved by the Board of Directors on 14 November 2025. * Standalone Performance (Q2 FY26): * Total Revenue from Operations increased to ₹49.53 crore from ₹43.25 crore in Q2 FY25. * Profit before tax rose to ₹52.78 crore from ₹42.49 crore in Q2 FY25. * Profit after tax stood at ₹39.56 crore, up from ₹34.52 crore in Q2 FY25. * Basic Earnings Per Share (EPS) was ₹37.96, compared to ₹34.69 in Q2 FY25. * The company reported an exceptional gain of ₹3.25 crore from the reversal of ESAR charge for unvested options. * Consolidated Performance (Q2 FY26): * Total Revenue from Operations was ₹1,781.92 crore, an increase from ₹1,705.48 crore in the previous quarter. * Profit before tax reached ₹145.77 crore, up from ₹132.76 crore in the previous quarter. * Profit after tax was ₹104.12 crore, compared to ₹99.78 crore in the previous quarter. * Basic EPS was ₹99.13, up from ₹95.00 in the previous quarter. * The Board also approved the allotment of 3,237 equity shares of ₹10 each upon the exercise of Equity Settled Stock Appreciation Rights (ESARs), increasing the paid-up share capital. * Key Appointments (effective 14 November 2025, subject to member approval for directors): * Mr. Sumit Mitra (DIN 07189815) appointed as an Additional Non-Executive Independent Director for a 5-year term. * Mr. Venkataramani Sathya Moorthy (DIN 00229998) appointed as an Additional Non-Executive Independent Director for a 5-year term. * Mr. Rahul Kirloskar (DIN 00007319) appointed as an Additional Non-Executive Director. * Mr. Bharathan Gopalakrishnan appointed as Chief Financial Officer and Key Managerial Personnel. * Mr. Rohan Sapkal appointed as Head Human Resources, effective from 1 January 2026. * A postal ballot will be conducted to seek member approval for the appointments of Mr. Rahul Kirloskar, Mr. Sumit Mitra, and Mr. Venkataramani Sathya Moorthy as Directors. The cut-off date for voting entitlement is 21 November 2025.

Filing to action

What to do with a filing like this

Kirloskar Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Kirloskar Industries Limited. Read the original for the full detail.

View original filing